A recent clinical trial has identified potential therapeutic benefits of cannabigerol (CBG), a cannabinoid that has not been as widely studied as THC or CBD. The study, conducted by researchers at Washington State University (WSU) and the University of California, Los Angeles (UCLA), indicates that CBG may significantly reduce anxiety and stress, and could also improve memory. See Also: CBG: The ‘Mother Cannabinoid’ May Hold Key To Treating Nonalcoholic Fatty Liver Disease Symptoms CBG’s Impact On Anxiety And StressPublished in the journal Scientific Reports, theresearch involved a double-blin…